AlphaYouPB
Schedule 13G filing
Paradigm Biocapital Advisors LP disclosed a 5.8% stake in Tyra Biosciences, Inc. (TYRA)
Paradigm Biocapital Advisors LP reported owning 5.8% of Tyra Biosciences, Inc. (TYRA) (3,473,453 shares) in a Schedule 13G filed Sep 17, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 17, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.